Form 8-K - Current report:
SEC Accession No. 0001558370-19-010800
Filing Date
2019-11-12
Accepted
2019-11-12 16:05:59
Documents
14
Period of Report
2019-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K omer-20191112x8k3397499.htm   iXBRL 8-K 32925
2 EX-99.1 ex-99d1.htm EX-99.1 150060
3 GRAPHIC ex-99d1g001.jpg GRAPHIC 3623
  Complete submission text file 0001558370-19-010800.txt   322917

Data Files

Seq Description Document Type Size
4 EX-101.SCH omer-20191112.xsd EX-101.SCH 3258
5 EX-101.LAB omer-20191112_lab.xml EX-101.LAB 15501
6 EX-101.PRE omer-20191112_pre.xml EX-101.PRE 10532
12 EXTRACTED XBRL INSTANCE DOCUMENT omer-20191112x8k3397499_htm.xml XML 4716
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 191209304
SIC: 2834 Pharmaceutical Preparations